Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11171914rdf:typepubmed:Citationlld:pubmed
pubmed-article:11171914lifeskim:mentionsumls-concept:C0027066lld:lifeskim
pubmed-article:11171914lifeskim:mentionsumls-concept:C0377265lld:lifeskim
pubmed-article:11171914lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:11171914pubmed:issue3lld:pubmed
pubmed-article:11171914pubmed:dateCreated2001-2-22lld:pubmed
pubmed-article:11171914pubmed:abstractTextPosthypoxic and postencephalitic myoclonus is often poorly controlled with current treatments. The authors successfully treated three patients with posthypoxic and postencephalitic myoclonus by using levetiracetam, a new antiepileptic drug. Levetiracetam appears to be a promising agent for treating action myoclonus caused by hypoxic and encephalitic brain injury-the degree of functional improvement may depend on the severity of associated motor dysfunction.lld:pubmed
pubmed-article:11171914pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11171914pubmed:languageenglld:pubmed
pubmed-article:11171914pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11171914pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11171914pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11171914pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11171914pubmed:statusMEDLINElld:pubmed
pubmed-article:11171914pubmed:monthFeblld:pubmed
pubmed-article:11171914pubmed:issn0028-3878lld:pubmed
pubmed-article:11171914pubmed:authorpubmed-author:ChoY WYWlld:pubmed
pubmed-article:11171914pubmed:authorpubmed-author:KramerR ERElld:pubmed
pubmed-article:11171914pubmed:authorpubmed-author:KraussG LGLlld:pubmed
pubmed-article:11171914pubmed:authorpubmed-author:BerginAAlld:pubmed
pubmed-article:11171914pubmed:authorpubmed-author:ReichS GSGlld:pubmed
pubmed-article:11171914pubmed:issnTypePrintlld:pubmed
pubmed-article:11171914pubmed:day13lld:pubmed
pubmed-article:11171914pubmed:volume56lld:pubmed
pubmed-article:11171914pubmed:ownerNLMlld:pubmed
pubmed-article:11171914pubmed:authorsCompleteYlld:pubmed
pubmed-article:11171914pubmed:pagination411-2lld:pubmed
pubmed-article:11171914pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11171914pubmed:meshHeadingpubmed-meshheading:11171914...lld:pubmed
pubmed-article:11171914pubmed:meshHeadingpubmed-meshheading:11171914...lld:pubmed
pubmed-article:11171914pubmed:meshHeadingpubmed-meshheading:11171914...lld:pubmed
pubmed-article:11171914pubmed:meshHeadingpubmed-meshheading:11171914...lld:pubmed
pubmed-article:11171914pubmed:meshHeadingpubmed-meshheading:11171914...lld:pubmed
pubmed-article:11171914pubmed:meshHeadingpubmed-meshheading:11171914...lld:pubmed
pubmed-article:11171914pubmed:meshHeadingpubmed-meshheading:11171914...lld:pubmed
pubmed-article:11171914pubmed:meshHeadingpubmed-meshheading:11171914...lld:pubmed
pubmed-article:11171914pubmed:meshHeadingpubmed-meshheading:11171914...lld:pubmed
pubmed-article:11171914pubmed:meshHeadingpubmed-meshheading:11171914...lld:pubmed
pubmed-article:11171914pubmed:year2001lld:pubmed
pubmed-article:11171914pubmed:articleTitleSuppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.lld:pubmed
pubmed-article:11171914pubmed:affiliationDepartment of Neurology, Johns Hopkins University, Baltimore, MD, USA. gkrauss@jhmi.edulld:pubmed
pubmed-article:11171914pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11171914pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11171914lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11171914lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11171914lld:pubmed